WO1998006436A3 - Inhibiting undesirable taste in oral compositions - Google Patents

Inhibiting undesirable taste in oral compositions Download PDF

Info

Publication number
WO1998006436A3
WO1998006436A3 PCT/US1997/013472 US9713472W WO9806436A3 WO 1998006436 A3 WO1998006436 A3 WO 1998006436A3 US 9713472 W US9713472 W US 9713472W WO 9806436 A3 WO9806436 A3 WO 9806436A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral compositions
undesirable taste
oral
inhibiting undesirable
undesirable
Prior art date
Application number
PCT/US1997/013472
Other languages
French (fr)
Other versions
WO1998006436A2 (en
Inventor
Sandra Lynn Nelson
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002263297A priority Critical patent/CA2263297C/en
Priority to AT97937072T priority patent/ATE234115T1/en
Priority to IL12848897A priority patent/IL128488A0/en
Priority to AU39676/97A priority patent/AU724235B2/en
Priority to BR9711159A priority patent/BR9711159A/en
Priority to JP50978598A priority patent/JP2001527518A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to HU0103016A priority patent/HUP0103016A3/en
Priority to EP97937072A priority patent/EP1077726B1/en
Priority to DE69719827T priority patent/DE69719827T2/en
Publication of WO1998006436A2 publication Critical patent/WO1998006436A2/en
Priority to NO990685A priority patent/NO990685L/en
Publication of WO1998006436A3 publication Critical patent/WO1998006436A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

The present invention relates to a method for inhibiting an undesirable taste in oral compositions such as foods, beverages, and pharmaceuticals. The present invention also relates to oral and pharmaceutical compositions comprising undesirable tasting compounds wherein undesirable tastes are inhibited by the addition of a phosphorylated amino acid, such as phosphotyrosine, phosphoserine, phosphothreonine, and mixtures thereof, to said oral and pharmaceutical compositions.
PCT/US1997/013472 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions WO1998006436A2 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT97937072T ATE234115T1 (en) 1996-08-14 1997-07-28 SUPPRESSION OF UNDESIRABLE TASTE IN ORAL COMPOSITIONS
IL12848897A IL128488A0 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral composition
AU39676/97A AU724235B2 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions
BR9711159A BR9711159A (en) 1996-08-14 1997-07-28 Inhibition of undesirable taste in oral compositions
JP50978598A JP2001527518A (en) 1996-08-14 1997-07-28 Suppression of undesirable taste in oral compositions
CA002263297A CA2263297C (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions
HU0103016A HUP0103016A3 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions
EP97937072A EP1077726B1 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions
DE69719827T DE69719827T2 (en) 1996-08-14 1997-07-28 SUPPRESSION OF UNWANTED TASTE IN ORAL COMPILATIONS
NO990685A NO990685L (en) 1996-08-14 1999-02-12 Method of incubating unwanted taste in oral compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/696,711 1996-08-14
US08/696,711 US5766622A (en) 1996-08-14 1996-08-14 Inhibiting undesirable taste in oral compositions

Publications (2)

Publication Number Publication Date
WO1998006436A2 WO1998006436A2 (en) 1998-02-19
WO1998006436A3 true WO1998006436A3 (en) 2000-12-21

Family

ID=24798232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/013472 WO1998006436A2 (en) 1996-08-14 1997-07-28 Inhibiting undesirable taste in oral compositions

Country Status (21)

Country Link
US (1) US5766622A (en)
EP (1) EP1077726B1 (en)
JP (1) JP2001527518A (en)
KR (1) KR100323271B1 (en)
CN (1) CN1306440A (en)
AR (1) AR009079A1 (en)
AT (1) ATE234115T1 (en)
AU (1) AU724235B2 (en)
BR (1) BR9711159A (en)
CA (1) CA2263297C (en)
CO (1) CO4920235A1 (en)
CZ (1) CZ48199A3 (en)
DE (1) DE69719827T2 (en)
HU (1) HUP0103016A3 (en)
ID (1) ID19356A (en)
IL (1) IL128488A0 (en)
NO (1) NO990685L (en)
PE (1) PE100598A1 (en)
TR (1) TR199900300T2 (en)
WO (1) WO1998006436A2 (en)
ZA (1) ZA977082B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6816934B2 (en) * 2000-12-22 2004-11-09 Hewlett-Packard Development Company, L.P. Computer system with registered peripheral component interconnect device for processing extended commands and attributes according to a registered peripheral component interconnect protocol
US6169118B1 (en) 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
WO2002002096A2 (en) * 2000-06-30 2002-01-10 The Procter & Gamble Company Oral compositions comprising host-response modulating agent
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
ITMI20012135A1 (en) 2001-10-16 2003-04-16 Bioren S A INJECTABLE SOLUTIONS READY TO USE PARACETAMOL
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
JP2005521662A (en) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド Transmucosal delivery of proton pump inhibitors
US7081264B2 (en) 2002-04-26 2006-07-25 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US6908637B2 (en) 2002-04-26 2005-06-21 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US20040091544A1 (en) * 2002-11-08 2004-05-13 Ruff Michael D. Coated dibasic calcium phosphate
TWI313598B (en) * 2002-12-18 2009-08-21 Wyeth Corp Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
JP2006518751A (en) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド Novel formulation for rapid and sustained suppression of gastric acid, omeprazole antacid complex-immediate release
EP1648417A4 (en) * 2003-07-18 2010-01-20 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20050084587A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Ice creams comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050238785A1 (en) * 2003-10-20 2005-10-27 Circle Group Holdings, Inc. Sauces comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084591A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Soups comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084589A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dressings comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084600A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dips comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP4435544B2 (en) * 2003-11-19 2010-03-17 高砂香料工業株式会社 Fruit juice-containing beverage
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
WO2005082154A1 (en) * 2004-02-26 2005-09-09 Wm. Wrigley Jr. Company Confections containing a blend of physilogical cooling agents
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050287273A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Processed cheeses comprising dietary fiber gel
US20050287275A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Sauces comprising dietary fiber gel
US20060286268A1 (en) * 2005-06-14 2006-12-21 Circle Group Holdings, Inc. Amorphous insoluble cellulosic fiber and method for making same
EP1993567A4 (en) 2005-10-27 2011-01-26 Lawrence Richard Bernstein Orally administrable gallium compositions and method of use
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
WO2013022948A1 (en) 2011-08-08 2013-02-14 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
US20160089439A1 (en) * 2014-09-28 2016-03-31 Satara Pharmaceuticals, LLC Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients
CA3177222A1 (en) * 2020-04-29 2021-11-04 Societe Des Produits Nestle S.A. A nutritional product containing a buffer composition and an amino acid and methods of using such a nutritional product

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003008A1 (en) * 1981-03-04 1982-09-16 Reynolds Eric Charles Caries inhibition
JPS59104310A (en) * 1982-12-07 1984-06-16 Lion Corp Composition for oral cavity

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US4031265A (en) * 1975-06-18 1977-06-21 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing bitterness in citrus juices
US4248141A (en) * 1978-08-18 1981-02-03 Miller Jr Harry W Method and apparatus for debittering soybeans
CH635732A5 (en) * 1979-01-26 1983-04-29 Nestle Sa PROCESS FOR DEAMERIZING A FRUIT OR VEGETABLE EXTRACT AND DESAMERIZED EXTRACT OBTAINED.
JPS56158707A (en) * 1980-04-08 1981-12-07 Lion Corp Composition for oral use
US4517379A (en) * 1981-06-26 1985-05-14 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5192563A (en) * 1986-10-22 1993-03-09 Wm. Wrigley, Jr. Company Strongly mint-flavored chewing gums with reduced bitterness and harshness
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
US4994490A (en) * 1989-04-03 1991-02-19 The Nutrasweet Company Novel N-(sulfomethyl)-N'-arylureas
US5266717A (en) * 1989-04-03 1993-11-30 Glenn Roy N-(sulfomethyl)-N'arylureas
JPH0354921A (en) * 1989-07-24 1991-03-08 Nec Corp Squelch signal generating circuit
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
JPH049335A (en) * 1990-04-25 1992-01-14 Aamu:Kk Method for removing bitterness and astringency of gymnema-sylvestre and beverage thereof
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
US5350839A (en) * 1990-10-15 1994-09-27 Taisho Pharmaceutical Co., Ltd. 2'-position modified compound of erythromycin or its derivative
JP3246738B2 (en) * 1990-11-30 2002-01-15 ロート製薬株式会社 Saponin and amino acid-containing composition
US5336513A (en) * 1991-02-20 1994-08-09 Kraft General Foods, Inc. Bitterness inhibitors
JPH0515389A (en) * 1991-07-12 1993-01-26 Terumo Corp Production of protein-like composition
DE4131118A1 (en) * 1991-09-19 1993-03-25 Henkel Kgaa METHOD FOR PRODUCING TASTE-NEUTRAL PASTS OF ALKYL ETHER SULFATES IN GLYCERINE
JPH0584288A (en) * 1991-09-25 1993-04-06 Terumo Corp Wound coating material
AU675778B2 (en) * 1991-11-27 1997-02-20 Bioresearch Inc. Specific eatable taste modifiers
DE4200821A1 (en) * 1992-01-15 1993-07-22 Bayer Ag TASTE-MASKED PHARMACEUTICAL AGENTS
JP2615345B2 (en) * 1992-12-28 1997-05-28 三栄源エフ・エフ・アイ株式会社 Taste improving agent and taste improving method
CN1065415C (en) * 1993-02-05 2001-05-09 花王株式会社 Taste modifying method and bitter taste reducing method
US5407921A (en) * 1993-07-01 1995-04-18 Kao Corporation Method for suppressing bitter taste

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982003008A1 (en) * 1981-03-04 1982-09-16 Reynolds Eric Charles Caries inhibition
JPS59104310A (en) * 1982-12-07 1984-06-16 Lion Corp Composition for oral cavity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 8430, Derwent World Patents Index; Class B05, AN 84185440, XP002046684 *

Also Published As

Publication number Publication date
BR9711159A (en) 1999-08-17
KR20000030006A (en) 2000-05-25
WO1998006436A2 (en) 1998-02-19
TR199900300T2 (en) 1999-06-21
KR100323271B1 (en) 2002-02-06
CZ48199A3 (en) 1999-06-16
CN1306440A (en) 2001-08-01
ZA977082B (en) 1998-03-04
HUP0103016A3 (en) 2002-06-28
IL128488A0 (en) 2000-01-31
DE69719827T2 (en) 2003-12-24
EP1077726B1 (en) 2003-03-12
US5766622A (en) 1998-06-16
NO990685L (en) 1999-04-12
AU3967697A (en) 1998-03-06
NO990685D0 (en) 1999-02-12
EP1077726A2 (en) 2001-02-28
AR009079A1 (en) 2000-03-08
DE69719827D1 (en) 2003-04-17
CA2263297A1 (en) 1998-02-19
HUP0103016A2 (en) 2001-12-28
JP2001527518A (en) 2001-12-25
PE100598A1 (en) 1999-01-06
ATE234115T1 (en) 2003-03-15
AU724235B2 (en) 2000-09-14
ID19356A (en) 1998-07-02
CA2263297C (en) 2003-10-28
CO4920235A1 (en) 2000-05-29

Similar Documents

Publication Publication Date Title
WO1998006436A3 (en) Inhibiting undesirable taste in oral compositions
WO2005102071B1 (en) Taste improving substances
DE69941544D1 (en) INGREDIENTS FOR THE SUPPRESSION OF BITTER TASTE
CA2383983A1 (en) Substituted indolealkanoic acids
CA2387738A1 (en) Process for producing a product containing antihypertensive tripeptides
HUP0103633A2 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors, process for preparation the compounds and pharmaceutical compositions containing the same
CA2392096A1 (en) Polymorphic form of atorvastatin calcium
WO2005049078A3 (en) Immunoglobulin preparations having increased stability
CA2437770A1 (en) Coffee compositions with enhanced flavor characteristics and method of making
CA2197106A1 (en) A mayonnaise-like product and a process for its manufacture
EP0631787A3 (en) Method for suppressing bitter taste of oral preparation.
ZA971850B (en) New aryl glycine amide derivatives, processes for preparing them and pharmaceutical compositions containing these compounds.
CA2263328A1 (en) Use of .gamma.-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
EP0791601A3 (en) An agent promoting bone formation and inhibiting bone resorption
WO2002016340A8 (en) Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
ZA200002610B (en) Flavor compounds.
EP0933030A3 (en) Pungent flavor components
CA2013772A1 (en) N-(sulfomethyl)-n'-arylureas
WO2002017735A3 (en) Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
AU5493298A (en) Stabilized pharmaceutical compositions and process for the preparation thereof
AU5819296A (en) Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
HUP0304046A2 (en) Dihydroimidazo[4,5-e]indole and 7h-pirrolo [3,2-f]-quinoxalin-derivatives, process for their preparation and pharmaceutical compositions containing them
ZA973952B (en) Methods and compositions for production of plant foodstuffs with enhanced sweet component of flavor.
WO2000036082A3 (en) NOVEL FUNGAL mRNA CAPPING ENZYMES, AND METHODS OF USING THE SAME
WO1999048851A3 (en) Processes for preparing intermediates

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97197342.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2263297

Country of ref document: CA

Ref document number: 2263297

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1999-481

Country of ref document: CZ

Ref document number: 1999/00300

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 1019997001271

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/001598

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1019997001291

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1199900128

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 1997937072

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1999-481

Country of ref document: CZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 1019997001271

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1019997001271

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1019997001291

Country of ref document: KR

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWP Wipo information: published in national office

Ref document number: 1997937072

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1019997001291

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1997937072

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1999-481

Country of ref document: CZ